Reuters logo
BRIEF-Teva announces FDA approval of Austedo tablets for treatment of tardive dyskinesia in adults
August 30, 2017 / 7:56 PM / 2 months ago

BRIEF-Teva announces FDA approval of Austedo tablets for treatment of tardive dyskinesia in adults

Aug 30 (Reuters) - Teva Pharmaceutical Industries Ltd

* Teva announces FDA approval of Austedo (deutetrabenazine) tablets for the treatment of tardive dyskinesia in adults Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below